Assessment of the stability of novel antibacterial triazolyl oxazolidinones using a stability-indicating high-performance liquid chromatography method

Medical Principles and Practice

Volumn 20, Issue 1, 2010, Pages 51-59

  Phillips, Oludotun A ^a   Sharaf, Leyla H ^a   Abdel Hamid, Mohammed E ^a   Varghese, Reny ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

High performance liquid chromatography; Mass spectrometry; Stability; Triazolyl oxazolidinones

Indexed keywords

3 [3 FLUORO(PIPERAZINIUM 1 YL)PHENYL 5 (4 METHYL 1H 1,2,3 TRIAZOL 1 YL)METHYLOXAZOLIDIN 2 ONE HYDROCHLORIDE]; 4 [2 FLUORO 4 (2 OXO 5 [1,2,3]TRIAZOL 1 YL METHYLOXAZOLIDIN 3 YL)PHENYL]PIPERAZINE 1 IUM HYDROCHLORIDE; ACETONITRILE; BUFFER; OXAZOLIDINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLUID; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; SIMULATION; STOMACH JUICE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; INTESTINAL MUCOSA; MASS SPECTROMETRY; OXAZOLIDINONES; STOMACH; TRIAZOLES;

EID: 78650434083     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319547     Document Type: Article

References (21)

1. Grau S, Rubio-Terrés C: Pharmacoeconomics of linezolid. Expert Opin Pharmacother 2008;9:987-1000.
2. Drew RH: Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections. Pharmacotherapy 2007;27:227-249.
3. Wilcox MH: Update on linezolid: the first oxazolidinone antibiotic. Expert Opin Pharmacother 2005;6:2315-2326.
4. Moellering RC: Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003;138:135-142.
5. Bozdogan B, Appelbaum PC: Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents 2004;23:113-119.
6. Sinclair A, Arnold C, Woodford N: Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci. Antimicrob Agents Chemother 2003;47:3620-3622.
7. Ippolito JA, Kanyo ZF, Wang D, Franceschi FJ, Moore PB, Steitz TA, Duffy EM: Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit. J Med Chem 2008;51:3353-3356.
8. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, Moellering RB Jr, Ferraro MJ: Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001;358:207-208.
9. Johnson AP, Tysall L, Stockdale MW, Woodford N, Kaufmann ME, Warner M, Livermore DM, Asboth F, Allerberger FJ: Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbiol Infect Dis 2002;21:751-754.
10. Jones RN, Kohno S, Ono Y, Ross JE, Yanagihara K: ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5, 591 Gram-positive clinical isolates in 23 countries. Diagn Microbiol Infect Dis 2009;64:191-201.
11. Phillips OA, Udo EE, Ali A A M, Al-Hassawi N: Synthesis and antibacterial activity of 5-substituted oxazolidinones. Bioorg Med Chem 2003;11:35-41.
12. Phillips OA, Udo EE, Ali A A M, Samuel SM: Synthesis and antibacterial activity of new N-linked 5-triazolylmethyl oxazolidinones. Bioorg Med Chem 2005;13:4113-4123.
13. Phillips OA, Udo EE, Ali A A M, Samuel SM: Structure-antibacterial activity of arylcarbonyland arylsulfonyl-piperazine 5-triazolylmethyl oxazolidinones. Eur Med Chem 2007;42:214-225.
14. Phillips OA, Udo EE, AbdelHamid ME, Varghese R: Synthesis and antibacterial activity of novel 5-(4-methyl-1H-1, 2, 3-triazole) methyl oxazolidinones. Eur Med Chem 2009;44:3217-3227.
15. Reck F, Zhou F, Girardot M, Kern G, Eyermann CJ, Hales NJ, Ramsay RR, Gravestock MB: Identification of 4-substituted 1, 2, 3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A. J Med Chem 2005;48:499-506.
16. Hauck SI, Cederberg C, Doucette A, Grosser L, Hales NJ, Poon G, Gravestock MB: New carbon-linked azole oxazolidinones with improved potency and pharmacokinetics. Bioorg Med Chem Lett 2007;17:337-340.
17. Phillips OA, Abdel-Hamid ME, Al-Hassawi N: Determination of linezolid in human plasma by LC-MS-MS. Analyst 2001;126:609-614.
18. Slatter JG, Stalker DJ, Feenstra KL, Welshman IR, Bruss JB, Sama JP, Johnson MG, Sanders PE, Hauer MJ, Fagerness PE, Stryd RP, Peng GW, Shobe EM: Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [14 C] linezolid to healthy human subjects. Drug Metab Dispos 2001;29:1136-1145.
19. Ji HY, Lee HW, Chang SG, Lee JJ, Rhee JK, Kim WB, Lee HS: Liquid chromatographytandem mass spectrometry for the determination of a new oxazolidinone antibiotic DA-7867 in human plasma. Biomed Chromatogr 2004;18:86-89.
20. Phillips OA, Abdel-Hamid ME: Determination of novel triazolylmethyl oxazolidinone concentrations in human plasma by APCILC-MS: application to stability study. J Pharmaceut Sci 2008;11:22s-31s.
21. Greene TW, Wuts P G M: Protective Groups in Organic Synthesis, ed 3. New York, Wiley, 1999, chapt 7, pp 503-550.